Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer.

Araki S, Omori Y, Lyn D, Singh RK, Meinbach DM, Sandman Y, Lokeshwar VB, Lokeshwar BL.

Cancer Res. 2007 Jul 15;67(14):6854-62.

2.

Interleukin-4 stimulates androgen-independent growth in LNCaP human prostate cancer cells.

Lee SO, Pinder E, Chun JY, Lou W, Sun M, Gao AC.

Prostate. 2008 Jan 1;68(1):85-91.

PMID:
18008330
3.

Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.

Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD, Yano S, Bar-Eli M, Radinsky R, Pettaway CA, Dinney CP.

Clin Cancer Res. 2000 May;6(5):2104-19.

4.
5.

Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells.

Levine L, Lucci JA 3rd, Pazdrak B, Cheng JZ, Guo YS, Townsend CM Jr, Hellmich MR.

Cancer Res. 2003 Jul 1;63(13):3495-502.

6.

CL1-GFP: an androgen independent metastatic tumor model for prostate cancer.

Patel BJ, Pantuck AJ, Zisman A, Tsui KH, Paik SH, Caliliw R, Sheriff S, Wu L, deKernion JB, Tso CL, Belldegrun AS.

J Urol. 2000 Oct;164(4):1420-5.

PMID:
10992426
7.

NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.

Jin RJ, Wang Y, Masumori N, Ishii K, Tsukamoto T, Shappell SB, Hayward SW, Kasper S, Matusik RJ.

Cancer Res. 2004 Aug 1;64(15):5489-95.

8.

Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.

Sun A, Tang J, Hong Y, Song J, Terranova PF, Thrasher JB, Svojanovsky S, Wang HG, Li B.

Prostate. 2008 Mar 1;68(4):453-61. doi: 10.1002/pros.20723.

PMID:
18196538
10.

Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R).

Ling MT, Wang X, Lee DT, Tam PC, Tsao SW, Wong YC.

Carcinogenesis. 2004 Apr;25(4):517-25. Epub 2003 Dec 19.

PMID:
14688027
12.

Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation.

Seaton A, Scullin P, Maxwell PJ, Wilson C, Pettigrew J, Gallagher R, O'Sullivan JM, Johnston PG, Waugh DJ.

Carcinogenesis. 2008 Jun;29(6):1148-56. doi: 10.1093/carcin/bgn109. Epub 2008 May 16.

PMID:
18487223
13.
14.

Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.

Gregory CW, Johnson RT Jr, Mohler JL, French FS, Wilson EM.

Cancer Res. 2001 Apr 1;61(7):2892-8.

15.

Role of coordinated molecular alterations in the development of androgen-independent prostate cancer: an in vitro model that corroborates clinical observations.

Shi Y, Chatterjee SJ, Brands FH, Shi SR, Pootrakul L, Taylor CR, Datar R, Cote RJ.

BJU Int. 2006 Jan;97(1):170-8.

16.

Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK.

Lee LF, Louie MC, Desai SJ, Yang J, Chen HW, Evans CP, Kung HJ.

Oncogene. 2004 Mar 18;23(12):2197-205.

PMID:
14767470
17.

Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour model.

Sato N, Gleave ME, Bruchovsky N, Rennie PS, Goldenberg SL, Lange PH, Sullivan LD.

J Steroid Biochem Mol Biol. 1996 May;58(2):139-46.

PMID:
8809195
18.

Interleukin-4 in patients with prostate cancer.

Takeshi U, Sadar MD, Suzuki H, Akakura K, Sakamoto S, Shimbo M, Suyama T, Imamoto T, Komiya A, Yukio N, Ichikawa T.

Anticancer Res. 2005 Nov-Dec;25(6C):4595-8.

19.
20.

Osteoblast-derived factors induce androgen-independent proliferation and expression of prostate-specific antigen in human prostate cancer cells.

Blaszczyk N, Masri BA, Mawji NR, Ueda T, McAlinden G, Duncan CP, Bruchovsky N, Schweikert HU, Schnabel D, Jones EC, Sadar MD.

Clin Cancer Res. 2004 Mar 1;10(5):1860-9.

Supplemental Content

Support Center